Eli Lilly Corp. buy BMO Capital Markets
Start price
07.02.24
/
50%
€666.00
Target price
07.02.25
€802.46
Performance (%)
28.09%
End price
08.02.25
€853.10
Summary
This prediction ended on 08.02.25 with a price of €853.10. The BUY prediction by BMO_Capital_Markets finished with a performance of 28.09%. BMO_Capital_Markets has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. Dividends of €4.82 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | -6.253% | -6.253% | 18.014% |
| iShares Core DAX® | 0.697% | -0.987% | 18.440% |
| iShares Nasdaq 100 | 1.661% | -1.837% | 9.500% |
| iShares Nikkei 225® | 0.922% | -7.458% | 10.635% |
| iShares S&P 500 | 0.430% | -0.851% | 3.017% |
Comments by BMO_Capital_Markets for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at BMO Capital Markets from $710.00 to $865.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Eli Lilly Corp.
Stopped prediction by BMO_Capital_Markets for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€842.00
03.07.24
03.07.24
€928.23
03.07.25
03.07.25
-21.39%
04.07.25
04.07.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€726.70
01.05.24
01.05.24
€936.94
01.05.25
01.05.25
-2.30%
02.05.25
02.05.25